Matrix Capital Management Company, LP Diversified Active

CIK: 0001410830 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $2,094,563 (100.0% shares, 0.0% debt)

Holdings (7)

— ALTAIR ENGR INC 56.7%

Value ($000) $1,187,189 Shares 12,430,000 Est. Cost $53.39 Unrealized —

GFS GLOBALFOUNDRIES INC 31.7%

Value ($000) $664,727 Shares 16,514,952 Est. Cost $56.72 Unrealized -18.2%

— PERIMETER SOLUTIONS SA 4.3%

Value ($000) $90,451 Shares 6,725,000 Est. Cost $13.89 Unrealized —

AURA AURA BIOSCIENCES INC 2.9%

Value ($000) $61,683 Shares 6,922,870 Est. Cost $14.82 Unrealized -42.1%

ZNTL ZENTALIS PHARMACEUTICALS INC 2.5%

Value ($000) $51,373 Shares 13,959,973 Est. Cost $29.98 Unrealized -87.9%

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 1.7%

Value ($000) $35,813 Shares 37,681,515 Est. Cost $7.17 Unrealized —

ADPT ADAPTIVE BIOTECHNOLOGIES COR 0.2%

Value ($000) $3,328 Shares 650,000 Est. Cost $44.30 Unrealized -90.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ALTAIR ENGR INC	12,430,000	$1,187,189	56.7%	$53.39	—	COM CL A	021369103
GFS	GLOBALFOUNDRIES INC	16,514,952	$664,727	31.7%	$56.72	-18.2%	ORDINARY SHARES	G39387108
—	PERIMETER SOLUTIONS SA	6,725,000	$90,451	4.3%	$13.89	—	COMMON STOCK	L7579L106
AURA	AURA BIOSCIENCES INC	6,922,870	$61,683	2.9%	$14.82	-42.1%	COM	05153U107
ZNTL	ZENTALIS PHARMACEUTICALS INC	13,959,973	$51,373	2.5%	$29.98	-87.9%	COM	98943L107
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	37,681,515	$35,813	1.7%	$7.17	—	SPONDS ADR	00653A107
ADPT	ADAPTIVE BIOTECHNOLOGIES COR	650,000	$3,328	0.2%	$44.30	-90.2%	COM	00650F109